Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis

Choi, D; Stewart, AP; Bhat, S

Bhat, S (通讯作者),Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.

ANNALS OF PHARMACOTHERAPY, 2022; 56 (5): 592

Abstract

Objective To review the pharmacological and clinical profile of ozanimod in the treatment of ulcerative colitis (UC). Data Sources A PubMed search was......

Full Text Link